Prediction of Treatment Efficacy and Telaprevir-Resistant Variants after Triple Therapy in Patients Infected with Hepatitis C Virus Genotype 1
Article Usage Stats Services JCM Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue JCM About JCM Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions & Com...
Gespeichert in:
| Veröffentlicht in: | Journal of Clinical Microbiology 2013-09, Vol.51 (9), p.2862-2868 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 2868 |
|---|---|
| container_issue | 9 |
| container_start_page | 2862 |
| container_title | Journal of Clinical Microbiology |
| container_volume | 51 |
| creator | Akuta, Norio Suzuki, Fumitaka Fukushima, Taito Kawamura, Yusuke Sezaki, Hitomi Suzuki, Yoshiyuki Hosaka, Tetsuya Kobayashi, Masahiro Hara, Tasuku Kobayashi, Mariko Saitoh, Satoshi Arase, Yasuji Ikeda, Kenji Kumada, Hiromitsu |
| description | Article Usage Stats
Services
JCM
Citing Articles
Google Scholar
PubMed
Related Content
Social Bookmarking
CiteULike
Delicious
Digg
Facebook
Google+
Mendeley
Reddit
StumbleUpon
Twitter
current issue
JCM
About
JCM
Subscribers
Authors
Reviewers
Advertisers
Inquiries from the Press
Permissions & Commercial Reprints
ASM Journals Public Access Policy
JCM
RSS Feeds
1752 N Street N.W. • Washington DC 20036
202.737.3600 • 202.942.9355 fax • journals@asmusa.org
Print ISSN:
0095-1137
Online ISSN:
1098-660X
Copyright © 2014
by the
American Society for Microbiology.
For an alternate route to
JCM
.asm.org, visit:
JCM
|
| doi_str_mv | 10.1128/JCM.01129-13 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmed_primary_23784126</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1439223350</sourcerecordid><originalsourceid>FETCH-LOGICAL-c443t-5297b7ffffe6ebf87a0b9ac6f086e72feba0f55191ac68f8a1c5e47fe307a7113</originalsourceid><addsrcrecordid>eNpVkctuFDEQRS0EIpPAjjUyOxZ08KPd7t4goVFIgoKI0BCxs6o95bSjfsX2JJqfyDfjYUIEtamS7_F1yZeQN5wdcy7qj1-X345ZnpqCy2dkwVlTF1XFfj0nC8YaVXAu9QE5jPGGMV6WSr0kB0LquuSiWpCHy4Brb5OfRjo5ugoIacAx0RPnvAW7pTCu6Qp7mAPe-VD8wOhjgkxcQfC5RwouYchX_dwjXXUYYN5SP9JLSB53wPno0CZc03ufOnqGcxaSj3RJr3zYRHqK45S2M1L-irxw0Ed8_diPyM8vJ6vlWXHx_fR8-fmisGUpU6FEo1vtcmGFras1sLYBWzlWV6iFwxaYU4o3PB_WrgZuFZbaoWQadP6RI_Jp7ztv2gHXNq8ZoDdz8AOErZnAm_-V0XfmerozUquykjuD948GYbrdYExm8NFi38OI0yYaXspGCCkVy-iHPWrDFGNA9_QMZ2YXockRmj8RGi4z_vbf1Z7gv5ll4N0e6Px1d-8DGoiDubGDUdw0RtSVkL8Bb8qmEQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1439223350</pqid></control><display><type>article</type><title>Prediction of Treatment Efficacy and Telaprevir-Resistant Variants after Triple Therapy in Patients Infected with Hepatitis C Virus Genotype 1</title><source>American Society for Microbiology</source><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><creator>Akuta, Norio ; Suzuki, Fumitaka ; Fukushima, Taito ; Kawamura, Yusuke ; Sezaki, Hitomi ; Suzuki, Yoshiyuki ; Hosaka, Tetsuya ; Kobayashi, Masahiro ; Hara, Tasuku ; Kobayashi, Mariko ; Saitoh, Satoshi ; Arase, Yasuji ; Ikeda, Kenji ; Kumada, Hiromitsu</creator><creatorcontrib>Akuta, Norio ; Suzuki, Fumitaka ; Fukushima, Taito ; Kawamura, Yusuke ; Sezaki, Hitomi ; Suzuki, Yoshiyuki ; Hosaka, Tetsuya ; Kobayashi, Masahiro ; Hara, Tasuku ; Kobayashi, Mariko ; Saitoh, Satoshi ; Arase, Yasuji ; Ikeda, Kenji ; Kumada, Hiromitsu</creatorcontrib><description>Article Usage Stats
Services
JCM
Citing Articles
Google Scholar
PubMed
Related Content
Social Bookmarking
CiteULike
Delicious
Digg
Facebook
Google+
Mendeley
Reddit
StumbleUpon
Twitter
current issue
JCM
About
JCM
Subscribers
Authors
Reviewers
Advertisers
Inquiries from the Press
Permissions & Commercial Reprints
ASM Journals Public Access Policy
JCM
RSS Feeds
1752 N Street N.W. • Washington DC 20036
202.737.3600 • 202.942.9355 fax • journals@asmusa.org
Print ISSN:
0095-1137
Online ISSN:
1098-660X
Copyright © 2014
by the
American Society for Microbiology.
For an alternate route to
JCM
.asm.org, visit:
JCM
</description><identifier>ISSN: 0095-1137</identifier><identifier>EISSN: 1098-660X</identifier><identifier>DOI: 10.1128/JCM.01129-13</identifier><identifier>PMID: 23784126</identifier><language>eng</language><publisher>United States: American Society for Microbiology</publisher><subject>Adult ; Aged ; Antiviral Agents - therapeutic use ; Asian Continental Ancestry Group ; Drug Therapy, Combination - methods ; Female ; Genotype ; Hepacivirus - classification ; Hepacivirus - genetics ; Hepacivirus - isolation & purification ; Hepatitis C virus ; Hepatitis C, Chronic - drug therapy ; Hepatitis C, Chronic - virology ; High-Throughput Nucleotide Sequencing ; Humans ; Interferon-alpha - therapeutic use ; Male ; Middle Aged ; Oligopeptides - therapeutic use ; Prognosis ; Ribavirin - therapeutic use ; RNA, Viral - genetics ; Treatment Outcome ; Virology ; Young Adult</subject><ispartof>Journal of Clinical Microbiology, 2013-09, Vol.51 (9), p.2862-2868</ispartof><rights>Copyright © 2013, American Society for Microbiology. All Rights Reserved. 2013 American Society for Microbiology</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c443t-5297b7ffffe6ebf87a0b9ac6f086e72feba0f55191ac68f8a1c5e47fe307a7113</citedby><cites>FETCH-LOGICAL-c443t-5297b7ffffe6ebf87a0b9ac6f086e72feba0f55191ac68f8a1c5e47fe307a7113</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3754631/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3754631/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,723,776,780,881,3175,3176,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23784126$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Akuta, Norio</creatorcontrib><creatorcontrib>Suzuki, Fumitaka</creatorcontrib><creatorcontrib>Fukushima, Taito</creatorcontrib><creatorcontrib>Kawamura, Yusuke</creatorcontrib><creatorcontrib>Sezaki, Hitomi</creatorcontrib><creatorcontrib>Suzuki, Yoshiyuki</creatorcontrib><creatorcontrib>Hosaka, Tetsuya</creatorcontrib><creatorcontrib>Kobayashi, Masahiro</creatorcontrib><creatorcontrib>Hara, Tasuku</creatorcontrib><creatorcontrib>Kobayashi, Mariko</creatorcontrib><creatorcontrib>Saitoh, Satoshi</creatorcontrib><creatorcontrib>Arase, Yasuji</creatorcontrib><creatorcontrib>Ikeda, Kenji</creatorcontrib><creatorcontrib>Kumada, Hiromitsu</creatorcontrib><title>Prediction of Treatment Efficacy and Telaprevir-Resistant Variants after Triple Therapy in Patients Infected with Hepatitis C Virus Genotype 1</title><title>Journal of Clinical Microbiology</title><addtitle>J Clin Microbiol</addtitle><description>Article Usage Stats
Services
JCM
Citing Articles
Google Scholar
PubMed
Related Content
Social Bookmarking
CiteULike
Delicious
Digg
Facebook
Google+
Mendeley
Reddit
StumbleUpon
Twitter
current issue
JCM
About
JCM
Subscribers
Authors
Reviewers
Advertisers
Inquiries from the Press
Permissions & Commercial Reprints
ASM Journals Public Access Policy
JCM
RSS Feeds
1752 N Street N.W. • Washington DC 20036
202.737.3600 • 202.942.9355 fax • journals@asmusa.org
Print ISSN:
0095-1137
Online ISSN:
1098-660X
Copyright © 2014
by the
American Society for Microbiology.
For an alternate route to
JCM
.asm.org, visit:
JCM
</description><subject>Adult</subject><subject>Aged</subject><subject>Antiviral Agents - therapeutic use</subject><subject>Asian Continental Ancestry Group</subject><subject>Drug Therapy, Combination - methods</subject><subject>Female</subject><subject>Genotype</subject><subject>Hepacivirus - classification</subject><subject>Hepacivirus - genetics</subject><subject>Hepacivirus - isolation & purification</subject><subject>Hepatitis C virus</subject><subject>Hepatitis C, Chronic - drug therapy</subject><subject>Hepatitis C, Chronic - virology</subject><subject>High-Throughput Nucleotide Sequencing</subject><subject>Humans</subject><subject>Interferon-alpha - therapeutic use</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Oligopeptides - therapeutic use</subject><subject>Prognosis</subject><subject>Ribavirin - therapeutic use</subject><subject>RNA, Viral - genetics</subject><subject>Treatment Outcome</subject><subject>Virology</subject><subject>Young Adult</subject><issn>0095-1137</issn><issn>1098-660X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpVkctuFDEQRS0EIpPAjjUyOxZ08KPd7t4goVFIgoKI0BCxs6o95bSjfsX2JJqfyDfjYUIEtamS7_F1yZeQN5wdcy7qj1-X345ZnpqCy2dkwVlTF1XFfj0nC8YaVXAu9QE5jPGGMV6WSr0kB0LquuSiWpCHy4Brb5OfRjo5ugoIacAx0RPnvAW7pTCu6Qp7mAPe-VD8wOhjgkxcQfC5RwouYchX_dwjXXUYYN5SP9JLSB53wPno0CZc03ufOnqGcxaSj3RJr3zYRHqK45S2M1L-irxw0Ed8_diPyM8vJ6vlWXHx_fR8-fmisGUpU6FEo1vtcmGFras1sLYBWzlWV6iFwxaYU4o3PB_WrgZuFZbaoWQadP6RI_Jp7ztv2gHXNq8ZoDdz8AOErZnAm_-V0XfmerozUquykjuD948GYbrdYExm8NFi38OI0yYaXspGCCkVy-iHPWrDFGNA9_QMZ2YXockRmj8RGi4z_vbf1Z7gv5ll4N0e6Px1d-8DGoiDubGDUdw0RtSVkL8Bb8qmEQ</recordid><startdate>20130901</startdate><enddate>20130901</enddate><creator>Akuta, Norio</creator><creator>Suzuki, Fumitaka</creator><creator>Fukushima, Taito</creator><creator>Kawamura, Yusuke</creator><creator>Sezaki, Hitomi</creator><creator>Suzuki, Yoshiyuki</creator><creator>Hosaka, Tetsuya</creator><creator>Kobayashi, Masahiro</creator><creator>Hara, Tasuku</creator><creator>Kobayashi, Mariko</creator><creator>Saitoh, Satoshi</creator><creator>Arase, Yasuji</creator><creator>Ikeda, Kenji</creator><creator>Kumada, Hiromitsu</creator><general>American Society for Microbiology</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7U9</scope><scope>H94</scope><scope>5PM</scope></search><sort><creationdate>20130901</creationdate><title>Prediction of Treatment Efficacy and Telaprevir-Resistant Variants after Triple Therapy in Patients Infected with Hepatitis C Virus Genotype 1</title><author>Akuta, Norio ; Suzuki, Fumitaka ; Fukushima, Taito ; Kawamura, Yusuke ; Sezaki, Hitomi ; Suzuki, Yoshiyuki ; Hosaka, Tetsuya ; Kobayashi, Masahiro ; Hara, Tasuku ; Kobayashi, Mariko ; Saitoh, Satoshi ; Arase, Yasuji ; Ikeda, Kenji ; Kumada, Hiromitsu</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c443t-5297b7ffffe6ebf87a0b9ac6f086e72feba0f55191ac68f8a1c5e47fe307a7113</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Antiviral Agents - therapeutic use</topic><topic>Asian Continental Ancestry Group</topic><topic>Drug Therapy, Combination - methods</topic><topic>Female</topic><topic>Genotype</topic><topic>Hepacivirus - classification</topic><topic>Hepacivirus - genetics</topic><topic>Hepacivirus - isolation & purification</topic><topic>Hepatitis C virus</topic><topic>Hepatitis C, Chronic - drug therapy</topic><topic>Hepatitis C, Chronic - virology</topic><topic>High-Throughput Nucleotide Sequencing</topic><topic>Humans</topic><topic>Interferon-alpha - therapeutic use</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Oligopeptides - therapeutic use</topic><topic>Prognosis</topic><topic>Ribavirin - therapeutic use</topic><topic>RNA, Viral - genetics</topic><topic>Treatment Outcome</topic><topic>Virology</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Akuta, Norio</creatorcontrib><creatorcontrib>Suzuki, Fumitaka</creatorcontrib><creatorcontrib>Fukushima, Taito</creatorcontrib><creatorcontrib>Kawamura, Yusuke</creatorcontrib><creatorcontrib>Sezaki, Hitomi</creatorcontrib><creatorcontrib>Suzuki, Yoshiyuki</creatorcontrib><creatorcontrib>Hosaka, Tetsuya</creatorcontrib><creatorcontrib>Kobayashi, Masahiro</creatorcontrib><creatorcontrib>Hara, Tasuku</creatorcontrib><creatorcontrib>Kobayashi, Mariko</creatorcontrib><creatorcontrib>Saitoh, Satoshi</creatorcontrib><creatorcontrib>Arase, Yasuji</creatorcontrib><creatorcontrib>Ikeda, Kenji</creatorcontrib><creatorcontrib>Kumada, Hiromitsu</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of Clinical Microbiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Akuta, Norio</au><au>Suzuki, Fumitaka</au><au>Fukushima, Taito</au><au>Kawamura, Yusuke</au><au>Sezaki, Hitomi</au><au>Suzuki, Yoshiyuki</au><au>Hosaka, Tetsuya</au><au>Kobayashi, Masahiro</au><au>Hara, Tasuku</au><au>Kobayashi, Mariko</au><au>Saitoh, Satoshi</au><au>Arase, Yasuji</au><au>Ikeda, Kenji</au><au>Kumada, Hiromitsu</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Prediction of Treatment Efficacy and Telaprevir-Resistant Variants after Triple Therapy in Patients Infected with Hepatitis C Virus Genotype 1</atitle><jtitle>Journal of Clinical Microbiology</jtitle><addtitle>J Clin Microbiol</addtitle><date>2013-09-01</date><risdate>2013</risdate><volume>51</volume><issue>9</issue><spage>2862</spage><epage>2868</epage><pages>2862-2868</pages><issn>0095-1137</issn><eissn>1098-660X</eissn><abstract>Article Usage Stats
Services
JCM
Citing Articles
Google Scholar
PubMed
Related Content
Social Bookmarking
CiteULike
Delicious
Digg
Facebook
Google+
Mendeley
Reddit
StumbleUpon
Twitter
current issue
JCM
About
JCM
Subscribers
Authors
Reviewers
Advertisers
Inquiries from the Press
Permissions & Commercial Reprints
ASM Journals Public Access Policy
JCM
RSS Feeds
1752 N Street N.W. • Washington DC 20036
202.737.3600 • 202.942.9355 fax • journals@asmusa.org
Print ISSN:
0095-1137
Online ISSN:
1098-660X
Copyright © 2014
by the
American Society for Microbiology.
For an alternate route to
JCM
.asm.org, visit:
JCM
</abstract><cop>United States</cop><pub>American Society for Microbiology</pub><pmid>23784126</pmid><doi>10.1128/JCM.01129-13</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0095-1137 |
| ispartof | Journal of Clinical Microbiology, 2013-09, Vol.51 (9), p.2862-2868 |
| issn | 0095-1137 1098-660X |
| language | eng |
| recordid | cdi_pubmed_primary_23784126 |
| source | American Society for Microbiology; MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central |
| subjects | Adult Aged Antiviral Agents - therapeutic use Asian Continental Ancestry Group Drug Therapy, Combination - methods Female Genotype Hepacivirus - classification Hepacivirus - genetics Hepacivirus - isolation & purification Hepatitis C virus Hepatitis C, Chronic - drug therapy Hepatitis C, Chronic - virology High-Throughput Nucleotide Sequencing Humans Interferon-alpha - therapeutic use Male Middle Aged Oligopeptides - therapeutic use Prognosis Ribavirin - therapeutic use RNA, Viral - genetics Treatment Outcome Virology Young Adult |
| title | Prediction of Treatment Efficacy and Telaprevir-Resistant Variants after Triple Therapy in Patients Infected with Hepatitis C Virus Genotype 1 |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-30T06%3A30%3A35IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Prediction%20of%20Treatment%20Efficacy%20and%20Telaprevir-Resistant%20Variants%20after%20Triple%20Therapy%20in%20Patients%20Infected%20with%20Hepatitis%20C%20Virus%20Genotype%201&rft.jtitle=Journal%20of%20Clinical%20Microbiology&rft.au=Akuta,%20Norio&rft.date=2013-09-01&rft.volume=51&rft.issue=9&rft.spage=2862&rft.epage=2868&rft.pages=2862-2868&rft.issn=0095-1137&rft.eissn=1098-660X&rft_id=info:doi/10.1128/JCM.01129-13&rft_dat=%3Cproquest_pubme%3E1439223350%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1439223350&rft_id=info:pmid/23784126&rfr_iscdi=true |